MedTrace Logo

Group-Based Brief Behavioral Therapy for Insomnia for Patients With Chronic Mental Illness

NCT07779499 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-08-21

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the effectiveness of a short-term, group-based Brief Behavioral Therapy for Insomnia (BBTI) intervention in chronic psychiatric patients at a hospital day ward.The main questions it aims to answer are:

1. Does the BBTI-based group intervention improve subjective sleep quality and reduce the severity of insomnia?
2. Does the intervention have a positive effect on psychological well-being and cardiometabolic/physical functions? Researchers will compare an experimental group to a waitlist control group to see if the intervention improves sleep quality, reduces insomnia-perpetuating behaviors, and enhances overall health status across various timeframes.

Participants will:

1. Attend four sessions that cover sleep structure education, relaxation techniques (including acupressure), sleep-promoting diet principles, and the proper use of sedative-hypnotic medications.
2. Write a daily sleep diary.
3. Complete three times of structured self-report questionnaires.
4. Undergo physiological and physical function assessments.

Conditions

Interventions

BEHAVIORAL

Brief Behavioral Treatment for Insomnia in chronic mental health

The intervention is a short-term group therapy based on Brief Behavioral Treatment for Insomnia (BBTI). Participants will undergo a 4-week program, consisting of one 60-minute group session held once a week. The core content of the sessions focuses on personalized behavioral prescriptions designed to rebuild sleep regularity, aiming to improve insomnia symptoms and regulate related physiological and psychological indicators in chronic psychiatric patients.

Sponsors & Collaborators

  • National Taiwan University

    collaborator OTHER

  • National Taiwan University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2026-11-10
Completion
2026-11-10

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07779499 on ClinicalTrials.gov